Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy
Open Access
- 1 April 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (7), 2210-2219
- https://doi.org/10.1158/1078-0432.ccr-07-1893
Abstract
Purpose: Investigations on the combination of radiotherapy with vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) antiangiogenic agents, which has the potential to improve the clinical outcome in cancer patients.Keywords
This publication has 23 references indexed in Scilit:
- Transcriptional network governing the angiogenic switch in human pancreatic cancerProceedings of the National Academy of Sciences, 2007
- Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian CarcinomaClinical Cancer Research, 2007
- Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivoBMC Cancer, 2007
- Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of RadiotherapyClinical Cancer Research, 2005
- Trimodal Cancer Treatment: Beneficial Effects of Combined Antiangiogenesis, Radiation, and ChemotherapyCancer Research, 2005
- Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosisThe Journal of Experimental Medicine, 2005
- Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endotheliumInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanismsThe FASEB Journal, 2003
- Tumor Response to Radiotherapy Regulated by Endothelial Cell ApoptosisScience, 2003
- Antiangiogenic agents can increase tumor oxygenation and response to radiation therapyRadiation Oncology Investigations, 1994